By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies said today it has received approval of its surface plasmon resonance-based HPV-DNA chip from the State Food and Drug Administration of China.

The chip can detect high-risk and low-risk genotypes by analyzing a patient sample on the company's fully automated SPR analyzer, Beijing-based China Medical Technologies said in a statement. It added that the chip can distinguish multiple human papillomavirus infections and determine the viral load.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.